Health experts urge federal leaders to commit to national pharmacare

Open letter signed by more than 1,200 experts in medicine, pharmacy, nursing, economics, and law

Eric Hoskins, chair of the Advisory Council on the Implementation of National Pharmacare, speaks during a news conference at the National Press Theatre in Ottawa on Wednesday, June 12, 2019. THE CANADIAN PRESS/Sean Kilpatrick

More than 1,200 Canadian health care and public policy experts have signed an open letter to federal party leaders, calling on each of them to commit to implementing a national pharmacare system.

They say comprehensive public medication programs have improved access and reduced costs everywhere they’ve been implemented and want to keep national pharmacare from becoming a partisan issue.

The group of experts from across the country includes professors of medicine, pharmacy, nursing, economics, political science and law — many of them recognized as leaders in their fields.

They note that, since the 1960s, five separate national commissions have concluded that universal pharmacare would be the fairest and most affordable way to ensure universal access to necessary medicines in Canada.

Steve Morgan of the University of BC says he believes an actual program has not yet materialized in part because industry stakeholders who stand to lose billions in revenue have waged a concerted lobby over the years to prevent it from happening.

“Part of the reason for having so many experts in an academic environment sign a letter of this nature is to remind Canadians that Canadian experts who are independent of stakeholders that might benefit from the status quo are consistently on side with moving forward,” Morgan said.

RELATED: Expert panel recommends Canada implement single-payer pharmacare plan

“(We are) trying to send a signal that if a government moves forward with this recommendation, experts will support them.”

The letter urges all parties to put a plan to implement a national drug program in their campaign platforms and to follow through with those plans. It says the issue has been studied at length, and calls for immediate action, beginning in 2020.

They are endorsing the model proposed by an expert panel, led by former Ontario health minister Dr. Eric Hoskins, that recently studied the issue and delivered recommendations to the Trudeau government for a phased-in rollout of a national drug plan.

Such a plan would result in savings of an approximately $5 billion annually, an average of $350 a year for each family, the panel concluded.

Teresa Wright, The Canadian Press

Like us on Facebook and follow us on Twitter

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Active number of COVID cases rises to 61 in central zone

Cases increased by 13 over the past 24 hours

230 new COVID-19 cases reported over the weekend

City of Red Deer has nine active cases

Conservatives call for Trudeau to testify at committee on WE Charity deal

Ethics Commissioner Mario Dion is already investigating whether Trudeau violated the Conflict of Interest Act

Genetic detectives begin work to trace spread of COVID-19 in Canada

The kinds of genetic technology being used for this project did not exist when SARS hit Canada in 2003

Sylvan Lake RCMP overwhelmed by Saturday’s crowded waterfront

“The sheer number of people at the beach is an indication that enforcement is not the solution.”